Overview

Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This study was done to determine if the use of a combination of preoperative rectal misoprostol 400µg used with intraoperative perivascular vasopressin is better than perivascular vasopressin used alone to decrease bleeding at myomectomy.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital of the West Indies
Treatments:
Arginine Vasopressin
Diuretics
Misoprostol
Vasopressins